Nasdaq

Cantor Fitzgerald Initiates Coverage of Cabaletta Bio (CABA) with Overweight Recommendation

Fintel reports that on October 24, 2023, Cantor Fitzgerald initiated coverage of Cabaletta Bio (NASDAQ:CABA) with a Overweight recommendation. As of October 5, 2023, the average one-year price target ...
Nasdaq

Cantor Fitzgerald Initiates Coverage of Korro Bio (KRRO) with Overweight Recommendation

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Korro Bio (NasdaqCM:KRRO) with a Overweight recommendation. As of April 24, 2025, the average one-year price target for ...
Investing

Cantor Fitzgerald downgrades Korro Bio stock to Neutral after lead asset failure

Investing.com - Cantor Fitzgerald downgraded Korro Bio Inc. (NASDAQ:KRRO) from Overweight to Neutral following the failure of the company’s lead asset for alpha-1 antitrypsin deficiency (AATD). The ...
ETF Daily News

Gossamer Bio FY2025 EPS Estimate Raised by Cantor Fitzgerald

Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Gossamer Bio in a report issued on Monday, March 24th. Cantor ...
Investing

Belite Bio stock retains Overweight rating at Cantor Fitzgerald

On Thursday, Cantor Fitzgerald reiterated its Overweight rating on Belite Bio, Inc, ADR (NASDAQ: BLTE), maintaining a positive outlook on the company’s prospects. With a market capitalization of ...